Photo of Yakup Ergün from obdh.com.tr
Feb 14, 2025, 09:29
Yakup Ergün: Long-Term Survival by ICIs in PD-L1–Negative mNSCLC
Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared a paper Ben Ponvilawan and colleagues on X:
“Long-Term Survival by ICIs in PD-L1–Negative mNSCLC
ICI-based therapy is more effective than ChT
In squamous histology, dual ICI regimens appear to be more effective than single ICI
In non-squamous, single or doublet ICI shows similar efficacy.”
Authors: Ben Ponvilawan et al.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 18, 2025, 19:27
Feb 18, 2025, 19:12
Feb 18, 2025, 19:03
Feb 18, 2025, 18:55
Feb 18, 2025, 18:13
Feb 18, 2025, 17:57
Feb 18, 2025, 17:36